Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfer from Subutex/Suboxone to RBP-6300 in opioid-dependent subjects
2011-003047-22Phase 2Completed
- Sponsor
- Indivior
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid use disorder (OUD) comparing Transfer to RBP-6300 with Continue Subutex/Suboxone (2 arms). Primary endpoint: Peak change from baseline in pre-dose COWS score. Started Sep 2011; status: completed.
02
Drugs
buprenorphineSuboxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2011-003047-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003047-22.